The effect of SQ14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing spontaneously hypertensive rat.
1979; Lippincott Williams & Wilkins; Volume: 1; Issue: 5 Linguagem: Inglês
10.1161/01.hyp.1.5.462
ISSN1524-4563
AutoresJoan T. Crofton, Leonard Share, Zola P. Horovitz,
Tópico(s)Birth, Development, and Health
ResumoHomeHypertensionVol. 1, No. 5The effect of SQ14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing spontaneously hypertensive rat. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBThe effect of SQ14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing spontaneously hypertensive rat. J T Crofton, L Share and Z P Horovitz J T CroftonJ T Crofton , L ShareL Share and Z P HorovitzZ P Horovitz Originally published1 Sep 1979https://doi.org/10.1161/01.HYP.1.5.462Hypertension. 1979;1:462–467 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Toba K, Ohta M, Kimura T, Nagano K, Ito S and Ouchi Y (1999) Role of brain vasopressin in regulation of blood pressure Advances in Brain Vasopressin, 10.1016/S0079-6123(08)61579-4, (337-349), . Fukuzawa M, Satoh J, Sagara M, Muto G, Muto Y, Nishimura S, Miyaguchi S, Qiang X, Sakata Y, Nakazawa T, Ikehata F, Ohta S and Toyota T (1997) Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo, Immunopharmacology, 10.1016/S0162-3109(96)00160-9, 36:1, (49-55), Online publication date: 1-Apr-1997. Zacharieva S, Orbetzova M, Angelova-Gateva P and Andonova K (1995) Effects of a single dose and short-term captopril treatment on some pressor and depressor humoral factors in healthy subjects, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/0952-3278(95)90059-4, 53:5, (377-380), Online publication date: 1-Nov-1995. Buisson S, Dalle M, Dauprat-Dalle P and Scalbert E (2008) Endocrine and hemodynamic responses to dopamine infusion in the guinea-pig: Effects of ACE inhibition with perindopril, Archives Internationales de Physiologie, de Biochimie et de Biophysique, 10.3109/13813459209000723, 100:5, (339-343), Online publication date: 1-Jan-1992. Berecek K, Wyss J and Swords B (2009) Alterations in Vasopressin Mechanisms in Captopril-Treated Spontaneously Hypertensive Rats, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641969109042108, 13:5, (1019-1031), Online publication date: 1-Jan-1991. Stier C, Benter I, Ahmad S, Zuo H, Selig N, Roethel S, Levine S and Itskovitz H (1989) Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats., Hypertension, 13:2, (115-121), Online publication date: 1-Feb-1989. Linas S, Marzec-Calvert R, Ullian M and O'Brien R (1988) Mechanism of the antihypertensive effect of K depletion in the spontaneously hypertensive rat, Kidney International, 10.1038/ki.1988.140, 34:1, (18-25), Online publication date: 1-Jul-1988. Ritter S, Dinh T, Stone S and Ross N (1988) Cerebroventricular dilation in spontaneously hypertensive rats (SHRs) is not attenuated by reduction of blood pressure, Brain Research, 10.1016/0006-8993(88)91574-0, 450:1-2, (354-359), Online publication date: 1-May-1988. Sladek C, Devine M, Felten S, Aravich P and Blair M (1988) Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat, Brain Research, 10.1016/0006-8993(88)91071-2, 445:1, (39-46), Online publication date: 1-Mar-1988. Oparil S, Daise M, Abrahams C, Winternitz S and Szidon J (2009) Hyperoxia-induced Converting Enzyme Insufficiency in Conscious Rat: Cardiovascular Effects, Experimental Lung Research, 10.3109/01902148709068813, 12:1, (37-56), Online publication date: 1-Jan-1987. Natoff I (1987) Preclinical studies on angiotensin converting enzyme inhibitors, Cardiovascular Drugs and Therapy, 10.1007/BF02125829, 1:1, (15-27), Online publication date: 1-Jan-1987. Weening J, Beukers J, Grond J and Elema J (1986) Genetic factors in focal segmental glomerulosclerosis, Kidney International, 10.1038/ki.1986.68, 29:4, (789-798), Online publication date: 1-Apr-1986. Säynäväulammi P (2009) Effects of Captopril on the Urinary Excretion of Prostanoids and Kallikrein in Spontaneously Hypertensive Rats, Acta Pharmacologica et Toxicologica, 10.1111/j.1600-0773.1986.tb00170.x, 59:4, (285-290) Zusman R (1984) Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors, Kidney International, 10.1038/ki.1984.119, 25:6, (969-983), Online publication date: 1-Jun-1984. Säynävälammi P, Pörsti I, Nurmi A, Seppälä E, Laitinen L, Manninen V, Ylitalo P and Vapaatalo H (2016) Differing Effects of Two Angiotensin Converting Enzyme Inhibitors, Captopril and CI-906, on Diuresis and the Urinary Excretion of Kallikrein and Prostaglandins in Spontaneously Hypertensive Rats, Scandinavian Journal of Urology and Nephrology, 10.1080/00365599.1984.11783710, 18:sup79, (23-27), Online publication date: 1-Jul-1984. Okuno T, Nagahama S, Lindheimer M and Oparil S (1983) Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril., Hypertension, 5:5, (653-662), Online publication date: 1-Sep-1983. Reid I, Schwartz J, Ben L, Maselli J and Keil L (1983) Interactions Between Vasopressin and the Renin–Angiotensin System The Neurohypophysis: Structure, Function and Control, Proceedings of the 3rd International Conference on the Neurohypophysis, 10.1016/S0079-6123(08)64414-3, (475-491), . Mullane K, Moncada S and Vane J (1983) Does Prostaglandin Release Contribute to the Hypotension Induced by Inhibitors of Angiotensin Converting Enzyme? Prostaglandins and the Kidney, 10.1007/978-1-4684-4277-9_21, (213-233), . Aldigier J, Plouin P, Guyene T, Thibonnier M, Corvol P and Menard J (1982) Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension, The American Journal of Cardiology, 10.1016/0002-9149(82)90359-9, 49:6, (1447-1452), Online publication date: 1-Apr-1982. Oliver J, Henderson I, McKeever A and Balment R (1982) THE RENIN-ANGIOTENSIN SYSTEM IN THE ABSENCE OF ANTIDIURETIC HORMONE, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1982.tb37437.x, 394:1 The Brattlebo, (275-277), Online publication date: 1-Oct-1982. Richer C, Doussau M and Giudicelli J (1982) MK 421 and prevention of genetic hypertension development in young spontaneously hypertensive rats, European Journal of Pharmacology, 10.1016/0014-2999(82)90571-4, 79:1-2, (23-29), Online publication date: 1-Apr-1982. Crofton J, Rockhold R, Share L, Wang B, Horovitz Z, Manning M and Sawyer W (1981) Effect of intracerebroventricular captopril on vasopressin and blood pressure in spontaneously hypertensive rats., Hypertension, 3:6_pt_2, (II-71), Online publication date: 1-Nov-1981.Trippodo N and Frohlich E (1981) Similarities of genetic (spontaneous) hypertension. Man and rat., Circulation Research, 48:3, (309-319), Online publication date: 1-Mar-1981. Stamoutsos B, Carpenter R and Grossman S (1981) Role of angiotensin-II in the polydipsia of diabetes insipidus in the Brattleboro rat, Physiology & Behavior, 10.1016/0031-9384(81)90146-3, 26:4, (691-693), Online publication date: 1-Apr-1981. Unger T, Rockhold R, Bönner G, Rascher W, Schaz K, Speck G, Schömig A and Ganten D (2009) Antihypertensive Effects of the Novel Converting-Enzyme Inhibitor YS 980 in Spontaneously Hypertensive Rats, Clinical and Experimental Hypertension, 10.3109/10641968109037172, 3:1, (121-140), Online publication date: 1-Jan-1981. THIBONNIER M, SOTO M, MENARD J, ALDIGER J, CORVOL P and MILLIEZ P (1981) Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril, European Journal of Clinical Investigation, 10.1111/j.1365-2362.1981.tb02012.x, 11:6, (449-453), Online publication date: 1-Dec-1981. Soto M, Thibonnier M, Sire O, Menard J, Corvol P and Milliez P (1981) Antihypertensive and hormonal effects of single oral doses of Captopril and Nifedipine in essential hypertension, European Journal of Clinical Pharmacology, 10.1007/BF00544592, 20:3, (157-161), . Ledingham J and Simpson F (2009) Effect of Captopril on Blood Pressure, Total Body Sodium and Fluid Consumption of Genetically Hypertensive (GH) and Normotensive (N) Rats, Clinical and Experimental Hypertension, 10.3109/10641968109037436, 3:6, (1239-1263), Online publication date: 1-Jan-1981. Rubin B, Antonaccio M and Horovitz Z (1980) The Renin-Angiotensin System, Converting Enzyme Inhibition, and Antihypertensive Therapy Progress in Hormone Biochemistry and Pharmacology, 10.1007/978-94-011-7712-2_1, (1-53), . Giudicelli J, Freslon J, Glasson S and Richer C (2009) Captopril and Hypertension Development in the SHR, Clinical and Experimental Hypertension, 10.3109/10641968009037162, 2:6, (1083-1096), Online publication date: 1-Jan-1980. Ferrone R and Antonaccio M (1979) Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225), European Journal of Pharmacology, 10.1016/0014-2999(79)90211-5, 60:2-3, (131-137), Online publication date: 1-Dec-1979. September 1979Vol 1, Issue 5 Advertisement Article InformationMetrics Copyright © 1979 by American Heart Associationhttps://doi.org/10.1161/01.HYP.1.5.462PMID: 396246 Originally publishedSeptember 1, 1979 PDF download Advertisement
Referência(s)